Tower Research Capital (TRC)’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31K Buy
2,985
+704
+31% +$7.32K ﹤0.01% 3372
2025
Q1
$30.1K Buy
2,281
+1,658
+266% +$21.9K ﹤0.01% 2609
2024
Q4
$11.2K Buy
623
+56
+10% +$1K ﹤0.01% 3742
2024
Q3
$9.14K Sell
567
-1,198
-68% -$19.3K ﹤0.01% 3899
2024
Q2
$47.7K Buy
1,765
+1,527
+642% +$41.2K ﹤0.01% 3138
2024
Q1
$4.64K Sell
238
-217
-48% -$4.23K ﹤0.01% 4651
2023
Q4
$9.41K Buy
455
+75
+20% +$1.55K ﹤0.01% 4390
2023
Q3
$12.1K Sell
380
-22
-5% -$699 ﹤0.01% 3927
2023
Q2
$13.5K Sell
402
-346
-46% -$11.6K ﹤0.01% 3740
2023
Q1
$31K Sell
748
-762
-50% -$31.6K ﹤0.01% 2967
2022
Q4
$51K Sell
1,510
-577
-28% -$19.5K ﹤0.01% 2335
2022
Q3
$102K Buy
2,087
+559
+37% +$27.3K ﹤0.01% 2551
2022
Q2
$60K Sell
1,528
-1,332
-47% -$52.3K ﹤0.01% 2719
2022
Q1
$106K Buy
2,860
+2,446
+591% +$90.7K ﹤0.01% 2157
2021
Q4
$41K Sell
414
-134
-24% -$13.3K ﹤0.01% 2924
2021
Q3
$68K Buy
548
+157
+40% +$19.5K ﹤0.01% 2715
2021
Q2
$49K Sell
391
-145
-27% -$18.2K ﹤0.01% 3046
2021
Q1
$73K Sell
536
-1,076
-67% -$147K ﹤0.01% 2826
2020
Q4
$147K Sell
1,612
-575
-26% -$52.4K ﹤0.01% 2002
2020
Q3
$163K Buy
2,187
+2,075
+1,853% +$155K ﹤0.01% 2758
2020
Q2
$10K Buy
+112
New +$10K ﹤0.01% 4019
2020
Q1
Sell
-405
Closed -$29K 3767
2019
Q4
$29K Buy
405
+403
+20,150% +$28.9K ﹤0.01% 1686
2019
Q3
$0 Sell
2
-116
-98% ﹤0.01% 4455
2019
Q2
$7K Buy
+118
New +$7K ﹤0.01% 2786
2019
Q1
Sell
-417
Closed -$34K 4203
2018
Q4
$34K Buy
417
+343
+464% +$28K ﹤0.01% 1553
2018
Q3
$35K Buy
74
+73
+7,300% +$34.5K ﹤0.01% 1985
2018
Q2
$1K Sell
1
-13
-93% -$13K ﹤0.01% 3508
2018
Q1
$4K Sell
14
-101
-88% -$28.9K ﹤0.01% 2805
2017
Q4
$34K Buy
115
+46
+67% +$13.6K ﹤0.01% 1640
2017
Q3
$37K Sell
69
-14
-17% -$7.51K ﹤0.01% 2249
2017
Q2
$50K Buy
+83
New +$50K 0.01% 751
2017
Q1
Sell
-18
Closed -$9K 3789
2016
Q4
$9K Buy
18
+4
+29% +$2K ﹤0.01% 2725
2016
Q3
$6K Buy
+14
New +$6K ﹤0.01% 2442